Fresenius Kabi (FRE.VI) — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Fresenius Kabi, a subsidiary of Fresenius SE, is a global healthcare company with a mission to provide essential medicines and technologies for infusion, transfusion, and clinical nutrition. The company reported over €8.6 billion in revenue in 2025 and is executing a strategic transformation plan, #FutureFresenius, with its REJUVENATE phase aimed at accelerating performance and long-term value creation. Its core strength lies in a vertically integrated model of development, manufacturing, and global supply chain management for a broad portfolio of hospital-centric products.

Critical CareChronic IllnessNutritionTransfusion Medicine

Technology Platform

Vertically integrated platform for the development, complex manufacturing, and global supply chain management of essential small molecule pharmaceuticals, biosimilars, clinical nutrition, and compatible medical devices.

Opportunities

Significant growth in biosimilars as key biologic patents expire, coupled with increasing global demand for cost-effective generic injectables and clinical nutrition driven by aging populations and rising chronic disease prevalence.

Digital integration of medical devices and data-driven nutrition tools presents an additional innovation frontier.

Risk Factors

Intense pricing pressure in generics and biosimilars threatens margins, while complex global manufacturing and supply chains are vulnerable to disruptions and quality issues.

Successful execution of the #FutureFresenius transformation strategy is critical to achieving growth targets.

Competitive Landscape

Competes with large generics firms (e.g., Viatris, Hikma) in pharmaceuticals, nutrition leaders (e.g., Nestlé Health Science, Abbott), and device makers (e.g., B. Braun, BD) in infusion technology. Its key advantage is vertical integration, offering bundled drug, nutrition, and device solutions for hospital efficiency.

More companies in Small Molecule Drugs →More companies in Austria →